avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Name | miRBASE accession |
---|---|
hsa-miR-29a-3p
|
MIMAT0000086 |
hsa-miR-29b-3p
|
MIMAT0000100 |
hsa-miR-29c-3p
|
MIMAT0000681 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
1.4 | 4.2 | GO:0008057 | eye pigment granule organization(GO:0008057) |
1.2 | 3.7 | GO:1900082 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
1.2 | 3.6 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
1.2 | 3.5 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
1.0 | 9.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.0 | 3.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
1.0 | 3.0 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.9 | 2.7 | GO:2000349 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
0.9 | 8.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 2.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.8 | 3.9 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 | 2.3 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.8 | 5.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.7 | 1.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.7 | 2.8 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.7 | 3.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 1.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.6 | 3.6 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.6 | 2.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.5 | 2.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.5 | 2.1 | GO:0048936 | visceral motor neuron differentiation(GO:0021524) peripheral nervous system neuron axonogenesis(GO:0048936) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.5 | 1.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.5 | 4.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.5 | 1.4 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.5 | 1.4 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.4 | 1.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.4 | 1.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.4 | 3.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 2.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.4 | 1.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 1.5 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 | 4.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 2.2 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 | 1.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.4 | 4.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 3.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 3.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 1.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.3 | 9.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.3 | 1.0 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.3 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 1.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 1.9 | GO:0090135 | positive regulation of synapse structural plasticity(GO:0051835) actin filament branching(GO:0090135) |
0.3 | 2.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 1.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.3 | 0.9 | GO:0035283 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 0.9 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.3 | 2.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.3 | 9.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 1.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 1.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 0.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 3.0 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 2.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 2.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.9 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.2 | 1.1 | GO:0036343 | negative regulation of extracellular matrix disassembly(GO:0010716) psychomotor behavior(GO:0036343) |
0.2 | 1.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 2.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.6 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.2 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.8 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.2 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.8 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.2 | 1.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 3.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.5 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.2 | 0.5 | GO:0060921 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.2 | 1.0 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.2 | 0.9 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.2 | 0.5 | GO:1902309 | regulation of heart rate by hormone(GO:0003064) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 7.7 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.7 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 1.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.5 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 3.7 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 2.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 5.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 1.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 2.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 3.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 1.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 1.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 2.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 3.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.6 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.1 | 1.9 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 1.0 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 1.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 2.4 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.1 | 1.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 0.8 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.1 | 1.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.5 | GO:0033600 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 1.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.1 | 0.4 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.1 | 2.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 1.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.5 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 2.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 2.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.6 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.5 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.2 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 0.7 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.1 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 1.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 1.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.6 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 1.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.4 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.1 | 0.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 2.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 1.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 3.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 1.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 1.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 6.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 1.2 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 3.3 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 1.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 1.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.8 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 1.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.4 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.0 | 7.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 1.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.0 | 6.6 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.0 | 1.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 1.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 1.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 2.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 1.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 2.5 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 3.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 1.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.2 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.0 | 2.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 1.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 1.8 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 1.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 1.2 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.9 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 1.0 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.4 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.0 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 1.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.5 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.1 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.0 | 1.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 1.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 4.4 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.2 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 2.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 1.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 1.6 | GO:0030855 | epithelial cell differentiation(GO:0030855) |
0.0 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.7 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 2.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 3.7 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 2.0 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 2.7 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 1.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 1.1 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 4.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 2.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.0 | 1.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 1.2 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 1.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 1.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.6 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 2.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 1.8 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.1 | GO:0071409 | response to cycloheximide(GO:0046898) cellular response to cycloheximide(GO:0071409) |
0.0 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.5 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.8 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 1.1 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 1.0 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.0 | 0.7 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.0 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.0 | 0.7 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.0 | 0.8 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:1990032 | parallel fiber(GO:1990032) |
1.1 | 9.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.8 | 2.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.7 | 2.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.5 | 2.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.4 | 2.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 5.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.7 | GO:0043260 | laminin-1 complex(GO:0005606) laminin-11 complex(GO:0043260) |
0.3 | 0.9 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.3 | 5.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.3 | 3.0 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 1.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 6.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 5.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.6 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.2 | 0.8 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.2 | 3.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 1.9 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 1.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 4.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 7.3 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 3.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 2.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 3.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 2.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.0 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 1.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 3.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 6.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 3.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 2.2 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.3 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 2.1 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.2 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.1 | 2.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 10.1 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 2.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 6.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 4.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 1.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 4.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 2.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 3.8 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 1.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 3.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 6.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 1.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 5.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.2 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 2.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 4.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 3.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.7 | GO:0005844 | polysome(GO:0005844) |
0.0 | 2.1 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 0.5 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 3.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 7.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 2.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 2.0 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 1.6 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 3.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 1.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 9.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.3 | 5.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.2 | 3.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.2 | 3.6 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.8 | 4.0 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.6 | 1.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.6 | 3.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.5 | 3.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.5 | 7.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.5 | 1.9 | GO:0032427 | GBD domain binding(GO:0032427) |
0.5 | 1.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 7.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 3.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.4 | 4.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 1.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.4 | 2.2 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 2.2 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.4 | 2.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 1.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.3 | 3.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.3 | 1.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.3 | 2.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.3 | 2.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 3.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.3 | 2.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 0.8 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.2 | 5.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 3.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.2 | 1.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 4.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.6 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.2 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 4.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 3.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 2.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.5 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.9 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 2.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 2.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 2.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 6.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.6 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 4.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 0.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 2.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 1.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 4.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 3.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 2.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.5 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.2 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 2.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.8 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 0.3 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 2.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 2.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.2 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 4.8 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 3.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 3.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 3.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 2.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 10.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 1.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 3.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 2.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 4.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 15.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) L-proline transmembrane transporter activity(GO:0015193) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 1.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 4.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 1.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 2.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.8 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 1.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 2.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 1.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 6.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 1.0 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 2.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) ceramide binding(GO:0097001) |
0.0 | 0.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 1.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 1.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 2.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 1.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 16.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 2.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 11.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 11.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 8.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 6.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 13.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 4.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 4.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 4.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 3.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 2.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 3.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 4.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 3.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 8.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 4.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 5.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 5.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.9 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 5.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 6.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 1.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 3.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 5.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 3.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 3.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 4.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 8.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 9.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 4.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 4.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 4.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 3.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 3.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 3.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 3.0 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 2.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 4.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 2.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |